PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® (lorlatinib), expanding the...

Yicai: WHO Says Rich Countries Should Fulfill Their Promise of Providing Vaccines Fairly

BRUSSELS--(BUSINESS WIRE)--At present, The World Health Organization (WHO) is working hard to purchase vaccines through its COVAX to ensure that vaccines can be distributed...

Iktos Announces Collaboration With Pfizer in AI for Drug Design

PARIS--(BUSINESS WIRE)--Iktos announced today the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few...

McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine

IRVING, Texas--(BUSINESS WIRE)--As a centralized distribution partner for the U.S. government’s COVID vaccine distribution effort, McKesson today began distributing the COVID-19 vaccine received from...

Recent Articles